肝特异性miR-122调控肝脏疾病的研究进展

杨颖卓; 康鹏; 高杰; 徐春林; 王诗美; 吴霞

doi:10.3969/j.issn.1001-5256.2014.05.025

肝特异性miR-122调控肝脏疾病的研究进展

DOI: 10.3969/j.issn.1001-5256.2014.05.025

哈尔滨医科大学附属第二医院感染病科

基金项目:

黑龙江省政府博士后资助基金(LRB2010-355)；

详细信息

中图分类号: R575
计量
- 文章访问数: 2615
- HTML全文浏览量: 27
- PDF下载量: 666
- 被引次数: 0
出版历程
- 出版日期: 2014-05-20

Research progress in liver-specific miR-122 in regulating liver diseases

Research funding:

摘要

摘要:
miRNA-122（miR-122）是肝特异性微小RNA,在肝脏的生理功能和疾病方面都有重要的作用。阐述了miR-122与脂肪性肝炎的相关性及可能机制,探讨了miR-122表达水平的改变参与调控HCV和HBV感染的作用及机制,并归纳了miR-122在肝细胞癌（HCC）的发生发展中的作用。认为miR-122在肝脏中的诸多功能可为未来研发治疗肝脏疾病的药物提供新的靶点及新的治疗策略。
- 微RNAs /
- 脂肪肝 /
- 肝炎病毒属 /
- 肝炎病毒,乙型 /
- 肝肿瘤 /
- 综述
Abstract:
MicroRNA- 122 ( miR- 122) , a liver- specific microRNA, has important functions in the physiological function and disease development of the liver. The association of miR- 122 with steatohepatitis and its possible action mechanism are described, and the effects of altered miR- 122 expression in regulating infections with hepatitis B virus and hepatitis C virus are discussed. In addition, the roles of miR- 122 in the development and progression of hepatocellular carcinoma are summarized. It is thought that the functions of miR- 122 in the liver provide a new target and therapeutic strategy for treatment of liver diseases.
- microRNAs /
- fatty liver /
- hepacivirus /
- hepatitis B virus /
- liver neoplasms /
- review

HTML全文

参考文献(34)

[1]WINTER J, JUNG S, KELLER S, et al.Many roads to maturity:miRNA biogenesis pathways and their regulation[J].Nature cell biology, 2009, 11 (3) :228-234.

[2] MAKEYEV EV, MANIATIS T.Multilevel regulation of gene expression by miRNAs[J].Science Signaling, 2008, 319 (5871) :1789-1790.

[3]HE MZ, ZHAO YL, LIU XD, et al.Screening and prediction of differential expression miRNA and their target genes in papillary thyroid carcinoma tissue[J].J Jilin Univ:Med Edit, 2013, 39 (1) :99-103. (in Chinese) 贺梦子, 赵银龙, 刘晓东, 等.甲状腺乳头状癌组织中差异表达miRNA及其靶基因的筛选和预测[J].吉林大学学报:医学版, 2013, 39 (1) :99-103.

[4]HUANG XM, CHEN X, JAI ZY.Progress of artificial microRNAs in cancer gene therapy[J].Chin J Cell Biol, 2013, 35 (7) :1018-1026. (in Chinese) 黄晓明, 陈翔, 贾振宇.人工microRNAs在肿瘤基因治疗中的研究[J].中国细胞生物学学报, 2013, 35 (7) :1018-1026.

[5]SONG YX, YUE ZY, WANG ZN, et al.MiRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation[J].Mol Cancer, 2011, 10 (1) :1-3.

[6]LUAN T, TONG L, XU W, et al.MiR-122 stimulates the apoptosis of hepatoma cell Huh-7[J].Prati Oncol, 2012, 26 (5) :428-431. (in Chinese) 栾天, 佟雷, 徐威, 等.MiR-122促进原发性肝细胞癌Huh-7细胞凋亡[J].实用肿瘤学杂志, 2012, 26 (5) :428-431.

[7]ESAU C, DAVIS S, MURRAY SF, et al.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J].Cell metabolism, 2006, 3 (2) :87-98.

[8]HSU S, WANG B, KOTA J, et al.Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver[J].J Clin Invest, 2012, 122 (8) :2871-2883.

[9]TSAI WC, HSU SD, HSU CS, et al.MiRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis[J].J Clin Invest, 2012, 122 (8) :2884-2897.

[10]DING X, DING J, NING J, et al.Circulating microRNA-122 as apotential biomarker for liver injury[J].Mol Med Rep, 202, 5 (6) :1428-1432.

[11]LAUDADIO I, MANFROID I, ACHOURI Y, et al.A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation[J].Gastroenterology, 2012, 142 (1) :119-129.

[12]KARLMARK KR, WEISKIRCHEN R, ZIMMERMANN HW, et al.Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis[J].Hepatology, 2009, 50 (1) :261-274.

[13]JOPLING CL, SCHTZ S, SARNOW P.Position-dependent function for a tandem miRNA miR-122-binding site located in the hepatitis C virus RNA genome[J].Cell Host Microbe, 2008, 4 (1) :77-85.

[14]LINDENBACH BD, RICE CM.Unravelling hepatitis C virus replication from genome to function[J].Nature, 2005, 436 (7053) :933-938.

[15]NORMAN KL, SARNOW P.Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by miRNA miR-122 involves distinct mechanisms[J].J Virol, 2010, 84 (1) :666-670.

[16]VILLANUEVA RA, JANGRA RK, YI M, et al.miR-122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes[J].Antiviral Res, 2010, 88 (1) :119-123.

[17]MACHLIN ES, SARNOW P, SAGAN SM.Masking the 5'terminal nucleotides of the hepatitis C virus genome by an unconventional miRNA-target RNA complex[J].Proc Natl Acad Sci U S A, 2011, 108 (8) :3193-3198.

[18]WILSON JA, ZHANG C, HUYS A, et al.Human Ago2 is required for efficient miRNA 122 regulation of hepatitis C Virus RNA accumulation and translation[J].J virol, 2011, 85 (5) :2342-2350.

[19]ROBERTS APE, LEWIS AP, JOPLING CL.miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components[J].Nucleic Acids Res, 2011, 39 (17) :7716-7729.

[20]LANFORD RE, HILDEBRANDT-ERIKSEN ES, PETRI A, et al.Therapeutic silencing of miRNA-122 in primates with chronic hepatitis C virus infection[J].Science, 2010, 327 (5962) :198-201.

[21]SARASIN-FILIPOWICZ M, KROL J, MARKIEWICZ I, et al.Decreased levels of miRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy[J].Nat Med, 2009, 15 (1) :31-33.

[22]HU J, XU Y, HAO J, et al.MiR-122 in hepatic function and liver diseases[J].Protein Cell, 2012, 3 (5) :364-371.

[23]CHEN Y, SHEN A, RIDER PJ, et al.A liver-specific miRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication[J].FASEB J, 2011, 25 (12) :4511-4521.

[24]FAN CG, WANG CM, TIAN C, et al.miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3[J].Oncol Rep, 2011, 26 (5) :1281-1286.

[25]WANG S, QIU L, YAN X, et al.Loss of miRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1-modulated P53 activity[J].Hepatology, 2012, 55 (3) :730-741.

[26]PEDERSEN IM, CHENG G, WIELAND S, et al.Interferon modulation of cellular miRNAs as an antiviral mechanism[J].Nature, 2007, 449 (7164) :919-922.

[27]XU J, ZHU X, WU L, et al.MiRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway[J].Liver Int, 2012, 32 (5) :752-760.

[28]ZENG C, WANG R, LI D, et al.A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma[J].Hepatology, 2010, 52 (5) :1702-1712.

[29]MIZUGUCHI Y, MISHIMA T, YOKOMURO S, et al.Sequencing and bioinformatics-based analyses of the miRNA transcriptome in hepatitis B-related hepatocellular carcinoma[J].PLoS One, 2011, 6 (1) :e15304.

[30]KARAKATSANIS A, PAPACONSTANTINOU I, GAZOULI M, et al.Expression of miRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance[J].Mol Carcinog, 2013, 52 (4) :297-303.

[31]ZHUANG P, LI ZY, WANG PC, et al.The functional characterization of the human liver-specific miR-122 expression in hepatocullar carcinoma[J].Chin J Immunol, 2013, 29 (7) :686-688. (in Chinese) 庄鹏, 李志莹, 王氵柏郴.肝特异性的miR-122对肝癌细胞增殖及凋亡的影响[J].中国免疫学杂志, 2013, 29 (7) :686-688.

[32]WANG L, XU Y.MicroRNAs-the important participant in oncogenesis[J].China Med Herald, 2012, 9 (6) :15-17. (in Chinese) 王玲, 徐艳.MicroRNAs (miRNAs) ———肿瘤形成过程中的重要参与者[J].中国医药导报, 2012, 9 (6) :15-17.

[33]BURCHARD J, ZHANG C, LIU AM, et al.miRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma[J].Mol Syst Biol, 2010, 6:402.

[34]YANG YP.Current perspectives in preventive and therapeutic strategies for hepatocellular carcinoma[J].J Clin Hepatol, 2013, 29 (1) :1-4. (in Chinese) 杨永平.肝细胞癌防治热点与策略[J].临床肝胆病杂志, 2013, 29 (1) :1-4.

施引文献

资源附件(0)

访问统计